Recent studies showed that some AVPR2 mutations could cause biased Gαq/11 protein coupling rather than R68W showed bias to coupling with Gαq/11 protein rather than V162A and wild-type receptor.

Characterizing a candidate therefore means resolving its behavior at each subtype rather than treating signaling lets teams understand how a co-agonist behaves across all of its intended targets rather than

designed as a continuous learning environment — supporting scientific reasoning as programs mature, rather than Misinterpretation does more than delay progress.

More than a technical overview, this is a story of curiosity, persistence, and using science to meet Rather than being discouraged by challenges, he views them as forcing functions for creativity and growth

The suppressive rather than activating effects of pGRP were confined to blood flow at a high shear rate Blockage of PTK2 or interference of CIB1 no more than slightly affected thrombus formation at a low shear

GPCR is much more than a podcast? Come check out the brand new Dr.

Here, the Schild plot becomes a diagnostic tool  rather than a checkbox test: Slopes >1  often mean incomplete to Partial Agonists Partial agonists complicate things—they activate receptors but less effectively than

grows, it becomes a searchable extension of Terry’s teaching — designed for repeated exposure rather than

Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical

in academia or biotech, the future belongs to research groups that can orchestrate ecosystems rather than He treats modeling as part of a continuum rather than a separate discipline.

The move comes less than three weeks after X4 pulled together a $55 million PIPE and amended a loan facility

This time with none other than Dr. Bryan Roth There are 10 open tickets available. Get yours now!

determine partner preference; or (iii) the dynamics of GPCR binding to different types of partners rather than

GPCR Podcast, we have none other than Dr. Marta Filizola!

Our guest is none other than Dr. Juan Jose Fung, Principal Scientist, at GPCR Therapeutics.

Our first guest speaker is none other than Dr. Ben Myers!

Unlocking the Secrets of Orthosteric Binding Understanding why some drugs bind better than others is

In this session, we work through: How allosteric ligands redistribute receptor species rather than displace In allosteric binding data interpretation, the curve reflects state transitions rather than competitive

Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous

Why GPCR Drug Discovery Is More Complex Than It Looks G protein-coupled receptors (GPCRs) have long occupied and the Microcircuit Model of GPCR Pharmacology Understanding GPCRs as allosteric proteins  rather than

This is more than review, it’s readiness.

A GPCR Internalization Tool Designed for Real Research Needs Built on more than two decade A GPCR Internalization

Clues that point to true multiple-site binding rather than two-stage GPCR biology: Disrupting G protein If the tracer binds faster than the displacer, early time points exaggerate tracer occupancy and underestimate

One potential solution is to develop analgesics that act at targets other than opioid receptors.

A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-Gi

Hassard is a commercial leader with more than three decades of experience leading sales and marketing

In less than a decade, nanobodies, or recombinant single-domain antibody fragments from camelids, have

This Chemistry Tools session was more industry focused than those before, and Maria shared the floor

and anxiety, has shown, in the last decade, increasing evidence of its antitumoral properties in more than

intermediate state complex comprising β1-AR and nucleotide-free Gs is more stable when binding a full agonist than